home contact company.overview news sitemap print

Screening & Optimization
Structure-based Drug Design
Stem Cell-based Approaches

High content imaging (endpoint / live cell)
Assay development for compound screening / target validation
Phenotypic screening
Chromobody® cell lines on demand

Cardiac Safety
ex vivo Models
Receptors

Gene cloning and expression services
Lentiviral transduction technologies
Full range of cellular assays

DigiWest High Content Profiling
RPPA-based Pathway Mapping
Ultrasensitive Protein Profiling
Custom Multiplex Immunoassays

GMP Analysis
Method Development and Validation
Consulting for GMP or GLP Issues

   

NMI TT is a subsidiary of NMI